Cargando…

Oral Proteasomal Inhibitors Ixazomib, Oprozomib, and Delanzomib Upregulate the Function of Organic Anion Transporter 3 (OAT3): Implications in OAT3-Mediated Drug-Drug Interactions

Organic anion transporter 3 (OAT3) is mainly expressed at the basolateral membrane of kidney proximal tubules, and is involved in the renal elimination of various kinds of important drugs, potentially affecting drug efficacy or toxicity. Our laboratory previously reported that ubiquitin modification...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Yunzhou, Liang, Zhengxuan, Zhang, Jinghui, You, Guofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997269/ https://www.ncbi.nlm.nih.gov/pubmed/33670955 http://dx.doi.org/10.3390/pharmaceutics13030314

Ejemplares similares

Interaction of Anticancer Drugs with Human Organic Anion Transporter hOAT4
por: Liu, Chenchang, et al.
Publicado: (2019)

Chloroquine and Hydroxychloroquine, as Proteasome Inhibitors, Upregulate the Expression and Activity of Organic Anion Transporter 3
por: Liang, Zhengxuan, et al.
Publicado: (2023)

Coordinate regulation of systemic and kidney tryptophan metabolism by the drug transporters OAT1 and OAT3
por: Granados, Jeffry C., et al.
Publicado: (2021)

Transport of Kynurenic Acid by Rat Organic Anion Transporters rOAT1 and rOAT3: Species Difference between Human and Rat in OAT1
por: Uwai, Yuichi, et al.
Publicado: (2013)

Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes
por: Wu, Wei, et al.
Publicado: (2017)

Acamprosate Is a Substrate of the Human Organic Anion Transporter (OAT) 1 without OAT3 Inhibitory Properties: Implications for Renal Acamprosate Secretion and Drug–Drug Interactions
por: Antonescu, Irina E., et al.
Publicado: (2020)

Organic Anion and Cation SLC22 “Drug” Transporter (Oat1, Oat3, and Oct1) Regulation during Development and Maturation of the Kidney Proximal Tubule
por: Gallegos, Thomas F., et al.
Publicado: (2012)

Organic anion transporters, OAT1 and OAT3, are crucial biopterin transporters involved in bodily distribution of tetrahydrobiopterin and exclusion of its excess
por: Ohashi, Akiko, et al.
Publicado: (2017)

Male-Dominant Activation of Rat Renal Organic Anion Transporter 1 (Oat1) and 3 (Oat3) Expression by Transcription Factor BCL6
por: Wegner, Waja, et al.
Publicado: (2012)

Arsenic and Mercury Containing Traditional Chinese Medicine (Realgar and Cinnabar) Strongly Inhibit Organic Anion Transporters, Oat1 and Oat3, In Vivo in Mice
por: Yu, Wen-Hao, et al.
Publicado: (2015)

Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity
por: Hu, S, et al.
Publicado: (2017)

Drug transporters OAT1 and OAT3 have specific effects on multiple organs and gut microbiome as revealed by contextualized metabolic network reconstructions
por: Jamshidi, Neema, et al.
Publicado: (2022)

Nano Ellagic Acid Counteracts Cisplatin-Induced Upregulation in OAT1 and OAT3: A Possible Nephroprotection Mechanism
por: Neamatallah, Thikryat, et al.
Publicado: (2020)

Recent Advances in Synthetic Drugs and Natural Actives Interacting with OAT3
por: Chen, Ying, et al.
Publicado: (2023)

Impaired Insulin Signaling Affects Renal Organic Anion Transporter 3 (Oat3) Function in Streptozotocin-Induced Diabetic Rats
por: Lungkaphin, Anusorn, et al.
Publicado: (2014)

Pharmacokinetics of gallic acid and protocatechuic acid in humans after dosing with Relinqing (RLQ) and the potential for RLQ-perpetrated drug–drug interactions on organic anion transporter (OAT) 1/3
por: Li, Ziqiang, et al.
Publicado: (2021)

Retraction: Impaired Insulin Signaling Affects Renal Organic Anion Transporter 3 (Oat3) Function in Streptozotocin-Induced Diabetic Rats
Publicado: (2018)

Organic Anion Transporters (OAT) and Other SLC22 Transporters in Progression of Renal Cell Carcinoma
por: Whisenant, Thomas C., et al.
Publicado: (2022)

Processing of oat: the impact on oat's cholesterol lowering effect
por: Grundy, Myriam M.-L., et al.
Publicado: (2018)

Model‐Informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor
por: Gupta, Neeraj, et al.
Publicado: (2018)

Perfluoroalkyl substances (PFASs) are substrates of the renal human organic anion transporter 4 (OAT4)
por: Louisse, Jochem, et al.
Publicado: (2022)

Delanzomib, a novel proteasome inhibitor, sensitizes breast cancer cells to doxorubicin‐induced apoptosis
por: Wang, Mopei, et al.
Publicado: (2019)

Validation of the 2(nd) Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis
por: Semren, Nora, et al.
Publicado: (2015)

OATE Conference
por: Araki, Huzihiro, et al.
Publicado: (1985)

Wild Oats
Publicado: (1899)

Oat Meal
Publicado: (1891)

Oat Meal
Publicado: (1874)

Protein kinase C regulates organic anion transporter 1 through phosphorylating ubiquitin ligase Nedd4–2
por: Yu, Zhou, et al.
Publicado: (2021)

To Be Oats or Not to Be? An Update on the Ongoing Debate on Oats for Patients With Celiac Disease
por: Spector Cohen, Inna, et al.
Publicado: (2019)

Identification of Structural Features for the Inhibition of OAT3-Mediated Uptake of Enalaprilat by Selected Drugs and Flavonoids
por: Ni, Yao, et al.
Publicado: (2020)

The kidney drug transporter OAT1 regulates gut microbiome–dependent host metabolism
por: Granados, Jeffry C., et al.
Publicado: (2023)

PAH clearance after renal ischemia and reperfusion is a function of impaired expression of basolateral Oat1 and Oat3
por: Bischoff, Ariane, et al.
Publicado: (2014)

Unusual Flavones from Primula macrocalyx as Inhibitors of OAT1 and OAT3 and as Antifungal Agents against Candida rugosa
por: Li, Xue, et al.
Publicado: (2019)

Cilastatin protects against imipenem-induced nephrotoxicity via inhibition of renal organic anion transporters (OATs)
por: Huo, Xiaokui, et al.
Publicado: (2019)

Commentary: To Be Oats or Not to Be? An Update on the Ongoing Debate on Oats for Patients With Celiac Disease
por: Fritz, Ronald D., et al.
Publicado: (2020)

Narrative Review on the Effects of Oat and Sprouted Oat Components on Blood Pressure
por: Liska, DeAnn J., et al.
Publicado: (2022)

Screening Oat Genotypes for Tolerance to Salinity and Alkalinity
por: Bai, Jianhui, et al.
Publicado: (2018)

Correction: Neamatallah et al. Nano Ellagic Acid Counteracts Cisplatin-Induced Upregulation in OAT1 and OAT3: A Possible Nephroprotection Mechanism. Molecules 2020, 25, 3031
por: Neamatallah, Thikryat, et al.
Publicado: (2023)

Sowing Wild Oats
Publicado: (1914)

3-D Nucleus Architecture in Oat × Maize Addition Lines
por: Idziak-Helmcke, Dominika, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jqolbv5uej00h781rdj2t9op09